<DOC>
	<DOC>NCT02235155</DOC>
	<brief_summary>The primary goal is to examine the efficacy and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Uzbekistan.</brief_summary>
	<brief_title>Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Meet legal criteria to obtain abortion Have an ongoing pregnancy of 1322 weeks gestation Be willing to undergo a surgical completion if necessary Have no contraindications to study procedures, according to provider Be willing and able to consent to procedure, either by reading consent document or by having consent document read to her Be willing to follow study procedures Known previous transmural uterine incision Known allergy to mifepristone or misoprostol/prostaglandin or other contraindications to the use of mifepristone or misoprostol Any contraindications to vaginal delivery, including placenta previa</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>